Advances in AAV-mediated gene replacement therapy for pediatric monogenic neurological disorders
Pediatric monogenetic diseases encompass a spectrum of debilitating neurological disorders that affect infants and children, often resulting in profound cognitive and motor impairments. Gene replacement therapy holds immense promise in addressing the underlying genetic defects responsible for these...
Saved in:
| Main Authors: | Livia Zhou, Yafeng Wang, Yiran Xu, Yaodong Zhang, Changlian Zhu |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2024-12-01
|
| Series: | Molecular Therapy: Methods & Clinical Development |
| Subjects: | |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S2329050124001736 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Developing AAV-delivered nonsense suppressor tRNAs for neurological disorders
by: Jiaming Wang, et al.
Published: (2024-07-01) -
AAV‐mediated Gene Therapy for Hereditary Deafness: Progress and Perspectives
by: Liyan Zhang, et al.
Published: (2024-12-01) -
iPSC-hepatocyte organoids as a novel platform to predict AAV gene therapy efficacy
by: Estelle Berreur, et al.
Published: (2025-06-01) -
Novel AAV capsids for intravitreal gene therapy of photoreceptor disorders
by: Marina Pavlou, et al.
Published: (2021-02-01) -
AAV-mediated transduction of songbird retina
by: Pranav Kumar Seth, et al.
Published: (2025-03-01)